Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Letter Commentary & Co-Mentions | Period / Date | Action |
|---|---|---|---|
“Shares declined as management cut revenue estimates, especially for exports, and lowered profit guidance due to $100 million in commercialization costs for new U.S. specialty products.” | Q2 2025 Jun 30, 2025 | Preview | |
“Exited the position due to concerns regarding potentially hefty U.S. tariffs on branded drugs and the Trump administration's focus on lowering Medicare drug prices.” | Q4 2025 Dec 31, 2025 | Preview |
Read unredacted commentary excerpts, portfolio weight disclosures, and high-conviction theses from hedge fund managers discussing $SUNPHARMA.NS.
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
